| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |